DBV Technologies | Vermögenswerte



Assets Veränderung Datum
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 750.62M 49.24M 2024-09
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
DBV Technologies USD 65.7M 27.36M 2024-12
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
PTC Therapeutics USD 2.66B 950.36M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
United Therapeutics USD 7.74B 379.9M 2025-03



DBV Technologies Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.